Indeed, Liu and colleague [9] have reported that the alterations in expression of efflux pumps such as p-glycoprotein (P-gp) could lead to damages in barrier integrity in diabetes and could be restored by insulin therapy. This evidence concerns the gene PGP and diabetes mellitus.